Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh

Fundación Universitaria Internacional de Colombia > Research > Scientific Production <http://repositorio.unib.org/view/divisions/unincol=5Fproduccion=5Fcientifica.html>
Ibero-american International University > Research > Scientific Production <http://repositorio.unib.org/view/divisions/uninimx=5Fproduccion=5Fcientifica.html>
Ibero-american International University > Research > Articles and Books <http://repositorio.unib.org/view/divisions/uninipr=5Fproduccion=5Fcientifica.html>
Universidad Internacional do Cuanza > Research > Scientific Production <http://repositorio.unib.org/view/divisions/unic=5Fproduccion=5Fcientifica.html> Open English Introduction: Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh. Methods: We collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival. Results: COVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79–4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients. Discussion: Risk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh. metadata Sharif, Nadim; Sharif, Nazmul; Khan, Afsana; Halawani, Ibrahim F.; Alzahrani, Fuad M.; Alzahrani, Khalid J.; Díez, Isabel De la Torre; Ramírez-Vargas, Debora L.; Kuc Castilla, Ángel Gabriel; Parvez, Anowar Khasru and Dey, Shuvra Kanti mail UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, debora.ramirez@unini.edu.mx, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED <http://repositorio.unib.org/id/eprint/9478/1/fpubh-11-1222868.pdf> (2023) Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh. Frontiers in Public Health, 11. ISSN 2296-2565